Send the link below via email or IMCopy
Present to your audienceStart remote presentation
- Invited audience members will follow you as you navigate and present
- People invited to a presentation do not need a Prezi account
- This link expires 10 minutes after you close the presentation
- A maximum of 30 users can follow your presentation
- Learn more about this feature in our knowledge base article
Do you really want to delete this prezi?
Neither you, nor the coeditors you shared it with will be able to recover it again.
Make your likes visible on Facebook?
You can change this under Settings & Account at any time.
Transcript of ARTIFICIAL KIDNEY
Currently we have no Competitor.
We are Coming with a Brand New Idea.
Our Target Market is Highly Enthusiastic.
We Need Financial Support to Launch our Product.
The function of the artificial kidney is achieved by circulating the blood through a membrane, which may be either a flat sheet or a bundle of hollow regenerated cellulose fibres in the form of cellophane that retain the unwanted waste materials. Multilayer fibres composed of numerous layers of needle-punched fabrics with varying densities may also be used and are designed to remove the waste materials rapidly and efficiently.
The development of artificial kidneys depends on the development of hollow fibre membrane. Polymer can be spun into hollow fibre membrane
DIFFERENT SHEDDING MECHANISMS IN WEAVING
Looks for the adjustment of total revenue and costs, and so the resulting profits.
Invention of a product that can save billions of lives.
To provide awareness about advancements in Bio-textile.
Invitation for Investors.
Availability of product.
Artificial kidney consists of a semi-permeable membrane, on one side of which blood passes while a special dialysate solution is passed along the other. The artificial kidney is made of polyacetate and polysulphone in equal proportions.
A New Project.
Scope of Reseach.
Opportunities of Profit.
Invite Market of Every Kind.
Good Business Proposal.
WHY INVEST WITH US?
NEED OF THIS PRODUCT?
25 Million Kidney Patients in Pakistan.
Ranal Failure takes 50,000 lives Every year in Pakistan.
This figure is projected to rise to 380 million by 2025.
Every patient had to go for dialysis that cost him Rs.200,000 annually.
One year patient survival on hemo dialysis is 75% and 98% after transplant.
3 years of age with male to female ratio 1.8:1
WHAT IS OUR POSITION IN MARKET?
Surface membrane, 0.8 - 2.0 m2;
Inner diameter, 180 µm;
Membrane thickness membrane, 15 µm.
Ordinary hemodialysis membranes are believed to have a mean pore diameter of 2 - 3 nm.
Biocompatible membranes have a larger pore size (4-10 nm)
Hollow polyster fibre.
Cuprammonium hollow fibre
Moderate mechanical strength and permeability.
Suppression of complementary activation
MEDICAL USE OF FIBER PROPERTIES
We have distributed workers, the task as per their qualities and expertise, to obtain a good quality product.
The financial needs of our men is taken care of, in accordance with rising rate of inflation in our country.
Proper medical and transportation allowances are provided to the workers.
This attributes a major part in the budget of our company.
Its management’s task to remove the obstacles that prevent people from doing their jobs correctly.
We check our budget frequently because frequent budget oversight prevents the budget from getting too far out of hand.
We keep regular forecast on resources usage, Doing so will ensure that we're fully utilizing the resources we have and that we have the right resources ready for the project.
Our project team is fully informed of the project budget forecast. An informed team is an empowered team that takes ownership of the project.
We go to great lengths to ensure that our suppliers and our state-of-the-art distribution warehouses maintain the highest standards, often above and beyond government regulations. Additionally, we routinely monitor product quality and safety systems to ensure compliance and customer satisfaction.
Includes mainly the production departments.
Identify where costs are arising from, as:
Research development projects
Bionics is mechanical/electronic replacement or enhancement of organs/parts of living organisms. The medical bionic implant/artificial organs market is a potentially growing one with a global market of $12.67 billion in 2012. It is expected to grow at a CAGR of 7.1% to reach $17.82 billion in 2017. Rising healthcare expenditure and emergence of new healthcare facilities in emerging economies provides growth opportunities for the medical bionic implants market. The artificial organs industry is under dramatic transformation globally and will witness significant changes in the coming years, primarily driven by innovation, globalization, and commoditization of products.
By Launching our product worldwide through online resources we maximize our potential for success due to a number of reasons:
We will not be limited by the geographical area that we can service, our supply will be universal.
Taxes costs will be eliminated.
Our services will be available 24/7.
We will gain new customers by utilizing multimedia and internet.
Personnel expenditures will be lowered by keeping a forecast of our budget.
Potential customers will locate our product easily.
We can create targeted communication.
Sufficient information about the product can be provided.
Our company plans to use a direct sales strategy, retailers, and the Internet to reach markets.
These channels are most appropriate because it saves time, reduces man force, and fast access to established distribution channels.
We have planned to manufacture our product locally so that better opportunities of employment can be provided.
Our supply will be universal and all skilled men shall be welcomed to play their part in the betterment of our product.
Karachi and Islamabad will be the hub of our production.
Too early to nail down costs of the device with high level of confidence, but likely to cost the payer equivalent or less than what is spent on a transplant patient. Operational lifetime can be projected as far as a decade, but it is possible that periodic maintenance will be required via doctor/hospital visits.
EXPECTED COST AND MAINTENANCE
A large scale (non-implantable) version of the device was tested on acute renal failure patients with success. This version used commercial-off-the-shelf polymermembrane technology, but it established that a combination of hemofilter and bioreactor could mimic kidney functionality. We have since (successfully) focused on miniaturizing the hemofilter and shown superior filtration parameters relative to conventional polymer membranes, and resolved cell sourcing for the bioreactor and confirmed their functional performance. To date tests have been done in pigs, sheep, and rodents. First clinical trials are planned for 2017.
• The need to process around 45 gallons each day in order to filter out nearly 2 quarts of waste product and extra water in the urine.
• Patients with chronic renal failure, treated twice weekly for 10 to 16 h.
• The design of Artificial Kidney is the only one of its kind
• It is small and is built using human friend materials described as being "medically safe."
• The simplicity of design and its small size make it unique.
• Past in-house tests separated the materials effectively. We are making great progress, and we are extremely excited about its potential.
• Though it is too early to establish prices, an implantable bio artificial kidney should cost much less than that of a chronic renal patient undergoing hemodialysis (who must pay for drugs).
Artificial Kidney device has been designed to not be rejected by the body, unlike transplantation, which risks rejection from the body.
It works like a human kidney by removing excess minerals and wastes from the body.
The device, can either be implanted or worn outside the body, will create urine immediately, unlike a human implanted kidney, which can sometimes take 2 weeks or longer to begin working.
Maryam Hijab Haider